CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

Chimeric antigen receptor T-cell (CAR-T) therapy has been prosperous in the treatment of patients with various types of relapsed/refractory (R/R) B-cell malignancies including diffuse large B-cell lymphoma (DLBCL), B-cell acute lymphoblastic leukemia (B-ALL), follicular lymphoma (FL), mantle cell ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria, Rahbarizadeh, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499460/
https://www.ncbi.nlm.nih.gov/pubmed/34620233
http://dx.doi.org/10.1186/s13287-021-02595-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499460/
https://www.ncbi.nlm.nih.gov/pubmed/34620233
http://dx.doi.org/10.1186/s13287-021-02595-0

Ejemplares similares